SCHEMBL13715474

SCHEMBL13715474

Oc1cccc2c1c1ccccc1n2-c1ccc(-c2ccc(-n3c4ccccc4c4c(O)cccc43)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ HDAC4 P56524 1/20 0.42
▸ MAPT P10636 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ TSHR P16473 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ APP P05067 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ SNCA P37840 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10064054 0.89 KDM4E (0.61) L3MBTL1KDM4EATMMAPTHTT
SCHEMBL31257232 0.89 KDM4E (0.61) L3MBTL1KDM4EATMMAPTHTT
SCHEMBL30692086 0.84 KDM4E (0.48) L3MBTL1KDM4EATMMAPTHTT
SCHEMBL13715325 0.84 KDM4E (0.48) L3MBTL1KDM4EATMMAPTHTT
SCHEMBL15078261 0.83 PPARG (0.47) L3MBTL1KDM4EATMHDAC4MAPT
SCHEMBL31257233 0.83 PPARG (0.47) L3MBTL1KDM4EATMHDAC4MAPT
SCHEMBL30707951 0.83 KDM4E (0.44) L3MBTL1KDM4EATMHDAC4MAPT
SCHEMBL27315913 0.83 KDM4E (0.41) L3MBTL1KDM4EATMHDAC4MAPT
SCHEMBL18124857 0.80 L3MBTL1 (0.57) L3MBTL1KDM4EATMHDAC4MAPT
SCHEMBL30022478 0.80 L3MBTL1 (0.57) L3MBTL1KDM4EATMHDAC4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362463-B2 Organometallic complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2013-01-29 — — US disclosed
US-8362463-B2 Organometallic complexes E. I. DU PONT DE NEMOURS AND COMPANY (US) 2013-01-29 — — US disclosed
US-20090206327-A1 ORGANOMETALLIC COMPLEXES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-08-20 — — US disclosed
US-20090206327-A1 ORGANOMETALLIC COMPLEXES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2009-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090206327-A1 ORGANOMETALLIC COMPLEXES SLC25A11, TIMM9, TIMM50 L3MBTL1 1088/4885KDM4E 2731/4885ATM 3135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback